![David Cade](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Cade
Direttore Tecnico/Scientifico/R&S presso TELIX PHARMACEUTICALS LIMITED
Profilo
David N.
Cade is currently a Member at the Australian Institute of Co. Directors and the Group Chief Medical Officer at Telix Pharmaceuticals Ltd.
He previously worked as the Chief Medical Officer at Cochlear Ltd.
and Sirtex Medical Pty Ltd.
Dr. Cade holds an MBA from Melbourne Business School, a doctorate from Monash University, and an MBA from Escuela Superior de Administración y Dirección de Empresas.
Posizioni attive di David Cade
Società | Posizione | Inizio |
---|---|---|
TELIX PHARMACEUTICALS LIMITED | Direttore Tecnico/Scientifico/R&S | 01/01/2024 |
Australian Institute of Co. Directors
![]() Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Precedenti posizioni note di David Cade
Società | Posizione | Fine |
---|---|---|
SIRTEX MEDICAL LIMITED | Direttore Tecnico/Scientifico/R&S | 01/10/2017 |
COCHLEAR LIMITED | Direttore Tecnico/Scientifico/R&S | - |
Formazione di David Cade
Melbourne Business School | Masters Business Admin |
Monash University | Doctorate Degree |
Escuela Superior de Administración y Dirección de Empresas | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
COCHLEAR LIMITED | Health Technology |
TELIX PHARMACEUTICALS LIMITED | Health Technology |
Aziende private | 2 |
---|---|
Sirtex Medical Pty Ltd.
![]() Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Sirtex Medical Ltd. manufactures, and distributes liver cancer treatments. It operates through the following geographical segments: Asia Pacific, Americas, and Europe, Middle East, and Africa. It offers targeted radiation therapy known as SIR Spheres Y-90 resin microspheres. The company was founded in 1997 and is headquartered in St Leonards, Australia. | Commercial Services |
Australian Institute of Co. Directors
![]() Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
- Borsa valori
- Insiders
- David Cade